Clinical AML Registry and Biomaterial Database of the AML Cooparative Group (AML-CG)

Clinical AML Registry and Biomaterial Database of the AML Cooparative Group (AML-CG) - AMLCG registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00020816

Enrollment

3500

Registered

2020-03-25

Start date

2011-12-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C92.0 C92.4 C92.5 C92.6 C92.7 C92.8 C92.9 C93.0 C94.0 C94.2 C94.4 C95.0

Interventions

Group 1: Data collection for all adult AML cases

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: AML as defined by WHO criteria (including acute promyelocytic leukemia (APL) ); Age >= 18 years; signed informed consent

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Descriptive statistical analysis on baseline parameters at initial diagnosis (blood laboratory, morphology, cytogenetics, immuno phenotype molecular biology). Description of therapy regimens (induktion therapy, consolidation, stem cell transplantation, maintenance therapy, palliative cytoreduction, hypomethylating substances). Description of the course of the disease (therapy success, relapse, survival, toxcicities)	—

Measure

Time frame

Descriptive statistical analysis on baseline parameters at initial diagnosis (blood laboratory, morphology, cytogenetics, immuno phenotype molecular biology). Description of therapy regimens (induktion therapy, consolidation, stem cell transplantation, maintenance therapy, palliative cytoreduction, hypomethylating substances). Description of the course of the disease (therapy success, relapse, survival, toxcicities)

—

Secondary

Measure	Time frame
Recruitment success; explorative new research questions	—

Countries

Germany

Contacts

Public ContactAnja Baumgartner

Klinikum der Universität München, Campus Großhadern

anja.baumgartner@med.uni-muenchen.de089 4400-77313

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 8, 2026